| Neuland Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.09 | 0.10 | 0.20 | 0.26 | 0.30 |
| Long Term Debt-Equity Ratio | 0.06 | 0.06 | 0.10 | 0.13 | 0.12 |
| Current Ratio | 1.87 | 1.67 | 1.43 | 1.30 | 1.24 |
| Fixed Assets | 1.27 | 1.51 | 1.25 | 1.07 | 1.18 |
| Inventory | 4.01 | 4.95 | 4.38 | 3.71 | 4.01 |
| Debtors | 4.29 | 4.24 | 4.00 | 4.21 | 4.60 |
| Interest Cover Ratio | 34.29 | 29.63 | 17.47 | 7.06 | 6.15 |
| PBIDTM (%) | 23.71 | 30.44 | 23.59 | 15.17 | 15.98 |
| PBITM (%) | 19.27 | 26.61 | 19.16 | 10.01 | 11.74 |
| PBDTM (%) | 23.15 | 29.54 | 22.50 | 13.75 | 14.07 |
| CPM (%) | 18.49 | 23.05 | 18.12 | 11.84 | 11.76 |
| APATM (%) | 14.05 | 19.22 | 13.69 | 6.68 | 7.52 |
| ROCE (%) | 18.61 | 33.13 | 20.64 | 9.24 | 11.12 |
| RONW (%) | 14.86 | 26.48 | 17.90 | 7.86 | 9.49 |